1. Home
  2. NRXP vs HSON Comparison

NRXP vs HSON Comparison

Compare NRXP & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • HSON
  • Stock Information
  • Founded
  • NRXP 2015
  • HSON 1999
  • Country
  • NRXP United States
  • HSON United States
  • Employees
  • NRXP N/A
  • HSON N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • HSON Professional Services
  • Sector
  • NRXP Health Care
  • HSON Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • HSON Nasdaq
  • Market Cap
  • NRXP 32.6M
  • HSON 23.1M
  • IPO Year
  • NRXP N/A
  • HSON N/A
  • Fundamental
  • Price
  • NRXP $3.06
  • HSON $8.59
  • Analyst Decision
  • NRXP Strong Buy
  • HSON
  • Analyst Count
  • NRXP 4
  • HSON 0
  • Target Price
  • NRXP $28.50
  • HSON N/A
  • AVG Volume (30 Days)
  • NRXP 193.0K
  • HSON 15.4K
  • Earning Date
  • NRXP 08-13-2025
  • HSON 08-07-2025
  • Dividend Yield
  • NRXP N/A
  • HSON N/A
  • EPS Growth
  • NRXP N/A
  • HSON N/A
  • EPS
  • NRXP N/A
  • HSON N/A
  • Revenue
  • NRXP N/A
  • HSON $138,031,000.00
  • Revenue This Year
  • NRXP N/A
  • HSON $0.80
  • Revenue Next Year
  • NRXP N/A
  • HSON $8.09
  • P/E Ratio
  • NRXP N/A
  • HSON N/A
  • Revenue Growth
  • NRXP N/A
  • HSON N/A
  • 52 Week Low
  • NRXP $1.10
  • HSON $8.26
  • 52 Week High
  • NRXP $6.01
  • HSON $18.99
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 44.37
  • HSON 49.45
  • Support Level
  • NRXP $3.03
  • HSON $8.26
  • Resistance Level
  • NRXP $3.53
  • HSON $8.79
  • Average True Range (ATR)
  • NRXP 0.17
  • HSON 0.30
  • MACD
  • NRXP -0.06
  • HSON 0.05
  • Stochastic Oscillator
  • NRXP 4.95
  • HSON 61.72

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: